Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
03/2010
03/11/2010WO2010027113A2 Process for preparing (s)-(-)-felodipine
03/11/2010WO2010026989A1 Ortho-substituted haloalkylsulfonanilide derivative and herbicide
03/11/2010WO2010026882A1 Dehydrobromination inhibitor
03/11/2010WO2010026365A1 N-myristoyl transferase inhibitors
03/11/2010WO2010026104A1 4-tetrahydropyran-aminopyridine derivatives and their medical use
03/11/2010WO2010026095A1 Novel benzamides, production thereof, and use thereof as medicaments
03/11/2010WO2010026075A1 Pyridine derivatives as inhibitors of hiv-i reverse transcriptase
03/11/2010WO2010011134A3 Ozonolysis of aromatics and/or olefins
03/11/2010WO2010007114A3 Heterocyclyl carbonic acid amides as antiproliferative agents, pdkl inhibitors
03/11/2010WO2009153272A3 Method for the iodination of aromatic and/or heteroaromatic compounds
03/11/2010US20100063294 Alcohol production method by reducing ester of lactone with hydrogen
03/11/2010US20100063267 Bi-functional compound positively charged at first ph and negatively charged at second ph, solid support comprising the bi-functional compound, and method of isolating nucleic acid using the same
03/11/2010US20100063113 Novel pharmaceutical salts and polymorphs of a factor xa inhibitor
03/11/2010US20100063112 Polymorph iii of 4-[4-(amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide
03/11/2010US20100063105 Pharmaceutical uses and synthesis of nicotinanilide-n-oxides
03/11/2010US20100063098 Pyridone derivatives as p38a mapk inhibitors
03/11/2010US20100063075 Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives
03/11/2010US20100063053 Heterocyclic inhibitors of mek and methods of use thereof
03/11/2010US20100063045 Novel pyridinecarboxylic acid (2-aminophenyl) amide derivative having urea structure
03/11/2010US20100063044 Substituted aniline derivatives
03/11/2010US20100063027 Amine Derivative Having NPY Y5 Receptor Antagonistic Activity
03/11/2010US20100062937 Benzanilides with insecticidal activity
03/11/2010US20100061928 Labelled analogues of halobenzamides as radiopharmaceuticals
03/11/2010CA2735208A1 Novel benzamides, production thereof, and use thereof as medicaments
03/10/2010EP2161291A2 Polymer
03/10/2010EP2161251A1 Alcohol production method by reducing ester or lactone with hydrogen
03/10/2010EP2160373A1 BENZO[a]FLUORANTHENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME
03/10/2010EP1948609B1 Process for the preparation of pyridylcarboxylic amides and esters
03/10/2010EP1751113B1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
03/10/2010EP1556385B1 Heterocyclocarboxamide derivatives
03/10/2010CN101668744A Process for producing 1-substituted-2-pyridone-3-carboxylic acid derivative
03/10/2010CN101668743A Glucokinase-activating substance
03/10/2010CN101668742A Bridged six-membered ring compounds
03/10/2010CN101665459A Method and device for synthesizing pyridine and methylpyridine
03/09/2010US7674936 For agriculture crops
03/09/2010US7674916 Processing a dicarbonyl compound to form cyclic compound; reacting with an alkylating agent to form a derivative having an alkylated ring nitrogen
03/09/2010US7674910 Process for preparing diimine compounds
03/09/2010US7674887 3'-{N'-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; thrombocytopenia and megakaryocytopoiesis treatment
03/09/2010US7674828 Urea antagonists of P2Y1receptor useful in the treatment of thrombotic conditions
03/09/2010US7674825 Cardiovascular disorders; stimulant of guanylate cyclase
03/09/2010US7674805 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
03/09/2010US7674768 Processes for preparing eptifibatide
03/09/2010CA2482346C Substituted phenylacetamides and their use as glucokinase activators
03/09/2010CA2336702C Sulfonylaminocarboxylic acid n-arylamides as guanylate cyclase activators
03/09/2010CA2306313C Dipeptide nitriles
03/04/2010WO2010025179A1 1-(4-ureidobenzoyl)piperazine derivatives
03/04/2010WO2010024772A1 Aspartyl protease inhibitors
03/04/2010WO2010023679A2 Preparation of triclopyr, its intermediate and butoxyethyl ester
03/04/2010WO2010023448A1 Novel potassium channel blockers
03/04/2010WO2010023446A1 Novel potassium channel blockers
03/04/2010WO2010023307A1 Novel urea and thiourea derivatives
03/04/2010WO2010022988A1 N-(2-aminophenyl)-4-[n-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (ms-275)polymorph b
03/04/2010WO2010022725A1 Pyridine derivatives as vegfr-2 receptor and protein tyrosine kinase inhibitors
03/04/2010US20100056794 Process for the preparation of 2,5-bis-(2,2,2-trifluoroethoxy)-n-(2-piperidyl-methyl)-benzamide and salts thereof
03/04/2010US20100056787 Chelating agents
03/04/2010US20100056783 Novel Process for the Preparation of Statins and their Pharmaceutically Acceptable Salts thereof
03/04/2010US20100056585 N-(2-Aminophenyl)-4-[N-(Pyridine-3-yl)-Methoxycarbonyl-Aminomethyl]-Benzamide (MS-275) Polymorph B
03/04/2010US20100056582 Modulators of LXR
03/04/2010US20100056579 Insecticidal n-substituted sulfoximines
03/04/2010US20100056522 Intraocular pressure-lowering agent comprising compound having histone deacetylase inhibitor effect as active ingredient
03/04/2010US20100055056 Agent for improving permeation of a drug into a nail and an external treating agent containing the same
03/04/2010US20100051924 Fluorene-containing compound and organic light emitting device employing the same
03/04/2010US20100051509 Halogen-free ionic liquids in naphtha desulfurization and their recovery
03/04/2010DE102008044715A1 Kationische Acylpyridinium-Derivate als Bleichaktivatoren Cationic acylpyridinium derivatives as bleach activators
03/04/2010CA2735373A1 Novel urea and thiourea derivatives
03/04/2010CA2735118A1 Butyrylcholinesterase ligands as diagnostic tools and treatment for diseases of the nervous system
03/04/2010CA2734551A1 Pyridine derivatives as vegfr-2 receptor and protein tyrosine kinase inhibitors
03/04/2010CA2733661A1 1-(4-ureidobenzoyl)piperazine derivatives
03/03/2010EP2159221A1 Glucagon receptor antagonists, preparation and therapeutic uses
03/03/2010EP2159216A1 Ih - Modulators
03/03/2010EP1937639B1 Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4)
03/03/2010EP1389183B1 Sulfonamide derivatives
03/03/2010EP1386908B1 Amine derivative with potassium channel regulatory function, its preparation and use
03/03/2010CN101663277A Process for production of binuclear metal complex
03/03/2010CN101663276A 2-aminopyridine derivatives useful as kinase inhibitors
03/03/2010CN101663275A Pyridine compounds for liquid-crystalline mixtures
03/03/2010CN101663274A Method for the hydrolysis of heteroaromatic nitriles in aqueous fluids
03/03/2010CN101659637A Preparation method of 2-chloro-3-cyanopyridine
03/02/2010US7671207 Coupling thiazolidine-2,4-dione with p-(2-alkylpyridyl-2-hydroxy-, Cl-, Br-, mesyl- or tosyl-ethoxybenzaldehyde in a solvent, an organic base and an organic acid catalyst and hydrogenating the product to form 5-[4-[2-(alkylpyridyl)2-hydroxy-, Cl-, Br-, mesyl- or tosylethoxy]benzyl-2,4-thiazolidinedione
03/02/2010US7671092 Paclitaxel enhancer compounds
03/02/2010US7671074 Have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others; N-{amino-[pyridin-2-yl-methyl)-amino]-methylene}-4-methylbenzenesulfonamide
03/02/2010US7671066 Derivatives of 1-phenyl-2-pyridynyl alkylene alcohols as phosphodiesterase inhibitors
03/02/2010US7670991 Substituted benzoylcyclohexenones and their use as herbicidal agents
03/02/2010US7670990 N-{2-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]ethyl }-2-trifluoromethylbenzamide; can be combined with other fungicides which provide mixtures showing a synergistic effect
02/2010
02/25/2010WO2010021378A1 Dye-sensitized photovoltaic device
02/25/2010WO2010021345A1 Metal complex and manufacturing method therefor
02/25/2010WO2009141547A3 Perpropionic acid composition that is stable in a basic medium
02/25/2010WO2009110985A3 Amide compounds, compositions and uses thereof
02/25/2010WO2009087238A9 Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies
02/25/2010US20100048893 Substituted arylalkanoic acid derivatives and use thereof
02/25/2010US20100048698 Macrocyclic diterpenes for treating conditions associated with protein kinase c
02/25/2010US20100048647 Nematicidal agent composition and method of using the same
02/25/2010US20100048646 N'-Cyano-N-Halogenalkylimidamide Derivatives
02/25/2010US20100048627 synergistic pharmaceutical combination for the prevention or treatment of diabetes
02/25/2010US20100048626 Aryl Substituted Pyridines and the Use Thereof
02/25/2010US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
02/25/2010US20100048588 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
02/25/2010US20100048585 Quinoline derivatives as antibacterial agents
02/25/2010US20100048584 Pyridyl derivatives and their use as therapeutic agents
02/25/2010US20100048571 Organic Compounds